#Drug_Development
LightNews LightNews
newsen.bsky.social
Enhancing Biologics Programs through Optimal Decision-Making in Development Lifecycle#None#Drug_Development#Biologics#Xtalks
Enhancing Biologics Programs through Optimal Decision-Making in Development Lifecycle
Join our upcoming free webinar to discover how early development strategies impact biologics performance and manufacturing, featuring expert insights.
third-news.com
November 11, 2026 at 2:11 PM
newsen.bsky.social
PharmaBlock CMC Lifecycle Strategy Forum: Enhancing Drug Development Efficiency#China#Nanjing#Drug_Development#CMC_Strategy#PharmaBlock
PharmaBlock CMC Lifecycle Strategy Forum: Enhancing Drug Development Efficiency
The PharmaBlock CMC Lifecycle Strategy Forum held in Nanjing on November 5 and 6 focused on strategic decision-making in drug development, enhancing efficiency and program readiness.
third-news.com
November 9, 2026 at 8:44 AM
newsen.bsky.social
Transforming Drug Development: Inovia Bio Launches InovaMine AI Platform#None#Drug_Development#Inovia_Bio#InovaMine
Transforming Drug Development: Inovia Bio Launches InovaMine AI Platform
Inovia Bio has launched InovaMine, a groundbreaking AI platform designed to streamline clinical data analysis and revolutionize drug development processes.
third-news.com
November 5, 2026 at 2:29 PM
newsen.bsky.social
Understanding Global Drug Development in Early-Stage Oncology: Insights from Experts#None#Drug_Development#Xtalks#Early-Stage_Oncology
Understanding Global Drug Development in Early-Stage Oncology: Insights from Experts
Join us for a comprehensive webinar on integrating Western and Asian markets in early-stage oncology drug development. Gain insights from industry leaders.
third-news.com
November 4, 2026 at 1:54 PM
newsen.bsky.social
Yuyu Pharma's Innovative Approach Linking Human and Animal Health for Drug Development#South_Korea#Seoul#Drug_Development#Animal_Health#Yuyu_Pharma
Yuyu Pharma's Innovative Approach Linking Human and Animal Health for Drug Development
Yuyu Pharma's CEO discusses a new strategy connecting human and animal health at BIOPLUS-INTERPHEX KOREA. Insights include innovative drug development pathways.
third-news.com
October 29, 2026 at 2:30 PM
newsen.bsky.social
Revolutionizing Drug Development: Inovia Bio Launches AI Expert System for Rapid Results#London#United_Kingdom#Drug_Development#AI_expert#Inovia_Bio
Revolutionizing Drug Development: Inovia Bio Launches AI Expert System for Rapid Results
Inovia Bio introduces its Falcon Workflows, a groundbreaking AI system that transforms drug development timelines, generating expert-level outputs in hours and enhancing developer efficiency.
third-news.com
October 20, 2026 at 3:03 PM
newsen.bsky.social
Anirvan Ghosh Joins Formation Bio as Senior Vice President of Translational Sciences#USA#New_York#Drug_Development#Formation_Bio#Anirvan_Ghosh
Anirvan Ghosh Joins Formation Bio as Senior Vice President of Translational Sciences
Formation Bio welcomes Anirvan Ghosh, a seasoned expert in drug development, as its new SVP, Head of Translational Sciences, to strengthen its pipeline.
third-news.com
October 8, 2026 at 1:39 PM
newsen.bsky.social
Veeva Summit 2026: Pioneering AI in Biopharma R&D and Quality Management#United_States#Veeva_Systems#Boston#AI_Innovations#Drug_Development
Veeva Summit 2026: Pioneering AI in Biopharma R&D and Quality Management
Join Veeva Summit 2026 in Boston as industry leaders unveil AI innovations driving R&D and quality in biopharma. An essential event for life sciences.
third-news.com
October 8, 2026 at 11:31 AM
newsen.bsky.social
Emerging Biotech Companies Embrace Veeva Basics for Accelerated Drug Development#USA#Drug_Development#Pleasanton#biotech_companies#Veeva_Basics
Emerging Biotech Companies Embrace Veeva Basics for Accelerated Drug Development
Over 175 emerging biotech firms are leveraging Veeva Basics to optimize drug development processes and enhance efficiency in their operations.
third-news.com
October 7, 2026 at 7:54 PM
newsen.bsky.social
Emerging Biotech Firms Accelerate Drug Development with Veeva Basics Implementation#USA#Veeva_Systems#biotech#Drug_Development#Pleasanton
Emerging Biotech Firms Accelerate Drug Development with Veeva Basics Implementation
Over 175 emerging biotech companies are rapidly adopting Veeva Basics to streamline pharmaceutical development and enhance operational efficiency.
third-news.com
October 7, 2026 at 11:49 AM
newsen.bsky.social
Emerging Biotech Firms Harness Veeva Basics for Optimized Drug Development#USA#Drug_Development#biotechnology#Pleasanton#Veeva_Basics
Emerging Biotech Firms Harness Veeva Basics for Optimized Drug Development
Over 175 emerging biotech companies are utilizing Veeva Basics to standardize their processes, enhancing operational efficiency and accelerating drug development.
third-news.com
October 7, 2026 at 11:05 AM
newsen.bsky.social
Veeva Basics: The Key to Faster Drug Development for Emerging Biotechs#USA#Veeva_Systems#Drug_Development#biotechnology#Pleasanton
Veeva Basics: The Key to Faster Drug Development for Emerging Biotechs
Over 175 emerging biotech firms are adopting Veeva Basics to enhance their drug development processes, optimizing efficiency and compliance in regulatory practices.
third-news.com
October 7, 2026 at 11:06 AM
newsen.bsky.social
Emerging Biotechs Adopt Veeva Basics for Enhanced Drug Development Processes#USA#Veeva_Systems#Drug_Development#biotechnology#Pleasanton
Emerging Biotechs Adopt Veeva Basics for Enhanced Drug Development Processes
More than 175 biotech firms are harnessing Veeva Basics to streamline operations and enhance drug development, supporting their growth from startup to commercialization.
third-news.com
October 7, 2026 at 11:05 AM
newsen.bsky.social
Digital CMC Consortium: A New Era of Biopharma Standardization for Drug Development#United_States#Drug_Development#Dover#Biopharmaceutical#Digital_CMC
Digital CMC Consortium: A New Era of Biopharma Standardization for Drug Development
The newly launched Digital CMC Consortium unites industry leaders to revolutionize biopharma processes with digital standards, promising swift and efficient drug development.
third-news.com
October 6, 2026 at 10:13 AM
newsen.bsky.social
Ajinomoto Bio-Pharma Services Unveils Revamped Global Brand to Showcase Specialization Strength#Japan#Tokyo#Drug_Development#Ajinomoto#Bio-Pharma
Ajinomoto Bio-Pharma Services Unveils Revamped Global Brand to Showcase Specialization Strength
Ajinomoto Bio-Pharma Services has launched a refreshed global brand embodying its commitment to specialization and innovation, enhancing drug development support.
third-news.com
October 5, 2026 at 11:06 AM
newsen.bsky.social
Clarenta Group Expands Early Drug Development Expertise with L2D Acquisition#Paris#France#Drug_Development#Clarenta_Group#Leads_To_Development
Clarenta Group Expands Early Drug Development Expertise with L2D Acquisition
Clarenta Group's acquisition of Leads To Development enhances its capabilities in early-stage drug development by integrating L2D's expertise.
third-news.com
October 1, 2026 at 3:10 PM
newsen.bsky.social
Leads To Development Joins Clarenta Group, Enhancing Early-Stage Drug Development Expertise#USA#Paris#Drug_Development#Clarenta_Group#Leads_To_Development
Leads To Development Joins Clarenta Group, Enhancing Early-Stage Drug Development Expertise
Leads To Development has officially joined the Clarenta Group, boosting Clarenta's capabilities in drug development strategies and trials.
third-news.com
October 1, 2026 at 8:22 AM
newsen.bsky.social
Clarenta Group Welcomes Leads To Development for Enhanced Early-Stage Drug Development Expertise#Paris#France#Drug_Development#Clarenta_Group#Leads_To_Development
Clarenta Group Welcomes Leads To Development for Enhanced Early-Stage Drug Development Expertise
Clarenta expands its capabilities by welcoming Leads To Development, strengthening its early-stage drug development services in the biotech sector.
third-news.com
October 1, 2026 at 5:15 AM
newsen.bsky.social
CellCarta and Imagene AI Strengthen Partnership for AI-Driven Biomarker Development in Drug Trials#Drug_Development#CellCarta#Imagene_AI
CellCarta and Imagene AI Strengthen Partnership for AI-Driven Biomarker Development in Drug Trials
CellCarta and Imagene AI announce an enhanced alliance to support biopharmaceutical firms in developing AI-based biomarker and companion diagnostic programs. This strategic partnership aims to ease the transition from research to clinical implementation.
third-news.com
October 1, 2026 at 1:20 PM
newsen.bsky.social
Global AI in Clinical Trials Market Forecast: Major Growth Ahead Through 2034#India#Drug_Development#Pune#patient_recruitment#AI_in_Clinical_Trials
Global AI in Clinical Trials Market Forecast: Major Growth Ahead Through 2034
The AI in Clinical Trials Market is expected to expand significantly, reaching USD 7.32 billion by 2034, fueled by advancements in patient recruitment and data analysis.
third-news.com
September 25, 2026 at 10:25 PM
newsen.bsky.social
Understanding the Impact of Residual Reagents in Drug Development: A Critical Webinar by Xtalks#None#Drug_Development#Xtalks_Webinar#Impurity_Control
Understanding the Impact of Residual Reagents in Drug Development: A Critical Webinar by Xtalks
Join an upcoming free webinar hosted by Xtalks to understand how residual reagents affect drug safety and efficacy in development processes.
third-news.com
September 21, 2026 at 12:40 PM
newsen.bsky.social
GBI Biomanufacturing Unveils SmartScale™ GMP Solutions for Rapid Drug Development#USA#Boston#Drug_Development#GBI_Biomanufacturing#SmartScale™
GBI Biomanufacturing Unveils SmartScale™ GMP Solutions for Rapid Drug Development
GBI Biomanufacturing introduces SmartScale™, a game-changing GMP solution aimed at expediting the clinical trial process for drug developers.
third-news.com
September 17, 2026 at 12:16 PM
newsen.bsky.social
ModernVivo Introduces Marketplace to Expedite Preclinical CRO Selection for Researchers#USA#Seattle#Drug_Development#ModernVivo#CRO_Selection
ModernVivo Introduces Marketplace to Expedite Preclinical CRO Selection for Researchers
ModernVivo has unveiled a revolutionary Marketplace service to streamline the process of connecting preclinical teams with qualified CROs, accelerating drug development timelines.
third-news.com
September 15, 2026 at 1:07 PM
newsen.bsky.social
Angel Bridge Selected as Certified Venture Capital by AMED for Drug Venture Ecosystem Enhancement#Japan#Drug_Development#Chiyoda#Angel_Bridge#AMED
Angel Bridge Selected as Certified Venture Capital by AMED for Drug Venture Ecosystem Enhancement
Angel Bridge has been chosen as a certified venture capital firm by AMED, aiming to enhance the drug venture ecosystem in Japan and support startups with funding.
third-news.com
August 27, 2026 at 5:31 AM
newsen.bsky.social
Biohaven's Innovative Drug Development Shows Promise in Latest Clinical Trials for Autoimmune Diseases and Epilepsy#USA#Biohaven#New_Haven#Clinical_Trials#Drug_Development
Biohaven's Innovative Drug Development Shows Promise in Latest Clinical Trials for Autoimmune Diseases and Epilepsy
Biohaven Ltd. recently reported significant advancements in its clinical trials, showcasing rapid progress in treating autoimmune diseases like Graves' disease and IgA nephropathy, and offering new hope for epilepsy patients.
third-news.com
August 10, 2026 at 8:04 PM